Cinctive Capital Management LP Adaptive Biotechnologies Corp Transaction History

Cinctive Capital Management LP

  • $1.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$25.17 - $36.85 $1.1 Million - $1.61 Million
-43,797 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$30.02 - $39.87 $1.31 Million - $1.75 Million
43,797 New
43,797 $1.49 Million
Q3 2020

Nov 16, 2020
SELL
$35.79 - $48.81 $1.55 Million - $2.11 Million
-43,267 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$24.95 - $48.38 $1.08 Million - $2.09 Million
43,267 New
43,267 $2.09 Million

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email